Alveolar wall apoptosis causes lung destruction and emphysematous changes.

Pulmonary emphysema is characterized by alveolar wall destruction and airspace enlargement. Recent evidence indicates that epithelial or endothelial apoptosis may be involved in the pathogenesis of emphysema. Here, we describe the induction of emphysematous changes, including airspace enlargement, alveolar wall destruction, and enhanced lung distensibility, in mice receiving a single intratracheal injection of active caspase-3 and Chariot, a newly developed protein transfection reagent. Epithelial apoptosis and enhanced elastolytic activity (optimal at pH 5.5) in bronchoalveolar lavage were noted. Emphysematous changes were also generated in mice receiving an intratracheal injection of nodularin, a proapoptotic serine/threonine kinase inhibitor. This murine model provides direct evidence that confirms that alveolar wall apoptosis causes emphysematous changes. Furthermore, this simple technique for protein transfection of lung tissue can be used in a variety of future applications.

[1]  Dena Leshkowitz,et al.  Identification of a Novel Hypoxia-Inducible Factor 1-Responsive Gene, RTP801, Involved in Apoptosis , 2002, Molecular and Cellular Biology.

[2]  M. Morris,et al.  A peptide carrier for the delivery of biologically active proteins into mammalian cells , 2001, Nature Biotechnology.

[3]  W R Rice,et al.  Type II pneumocyte-CD8+ T-cell interactions. Relationship between target cell cytotoxicity and activation. , 2001, American journal of respiratory cell and molecular biology.

[4]  Marcel Leist,et al.  Cathepsin B Acts as a Dominant Execution Protease in Tumor Cell Apoptosis Induced by Tumor Necrosis Factor , 2001, The Journal of cell biology.

[5]  D A Lynch,et al.  Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. , 2001, American journal of respiratory and critical care medicine.

[6]  P. Hirth,et al.  Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. , 2000, The Journal of clinical investigation.

[7]  S. Shapiro,et al.  Vascular atrophy and VEGFR-2 signaling: old theories of pulmonary emphysema meet new data. , 2000, The Journal of clinical investigation.

[8]  D. Turk,et al.  Lysosomal cysteine proteases: more than scavengers. , 2000, Biochimica et biophysica acta.

[9]  M. Gaxiola,et al.  Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. , 2000, Chest.

[10]  B. Zhivotovsky,et al.  Ultrarapid caspase-3 dependent apoptosis induction by serine/threonine phosphatase inhibitors , 1999, Cell Death and Differentiation.

[11]  L. Fabbri,et al.  CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[12]  K. Aoshiba,et al.  H2O2 induces apoptosis in bovine tracheal epithelial cells in vitro. , 1999, Life sciences.

[13]  T. Welte,et al.  Expression of cathepsin K in lung epithelial cells. , 1999, American journal of respiratory cell and molecular biology.

[14]  P. Libby,et al.  Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. , 1998, The Journal of clinical investigation.

[15]  H. Chapman,et al.  Emerging roles for cysteine proteases in human biology. , 1997, Annual review of physiology.

[16]  W. Bode,et al.  HUMAN CATHEPSIN G , 1997 .

[17]  Alan D. Lopez,et al.  Evidence-Based Health Policy--Lessons from the Global Burden of Disease Study , 1996, Science.

[18]  D. Mcnulty,et al.  Proteolytic Activity of Human Osteoclast Cathepsin K , 1996, The Journal of Biological Chemistry.

[19]  D. Brömme,et al.  Human Cathepsin O2, a Matrix Protein-degrading Cysteine Protease Expressed in Osteoclasts , 1996, The Journal of Biological Chemistry.

[20]  S. Weiss,et al.  Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[21]  S. Shapiro,et al.  Human 92- and 72-kilodalton type IV collagenases are elastases. , 1991, The Journal of biological chemistry.

[22]  G. Snider.  Chronic obstructive pulmonary disease: risk factors, pathophysiology and pathogenesis. , 1989, Annual review of medicine.

[23]  M. Cosio,et al.  Destructive index: a measurement of lung parenchymal destruction in smokers. , 2015, The American review of respiratory disease.

[24]  M. Williams,et al.  Metabolic properties and ultrastructure of alveolar type II cells isolated with elastase. , 1980, Biochimica et biophysica acta.

[25]  K. Yoneda,et al.  The type II epithelial cell of the lung. I. Method of isolation. , 1974, Laboratory investigation; a journal of technical methods and pathology.